Comparison of the Effects of DOTA and NOTA Chelators on (64)Cu-Cudotadipep and (64)Cu-Cunotadipep for Prostate Cancer

Background: This study compared the effects of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) as (64)Cu-chelating agents in newly developed prostate-specific membrane antigen (PSMA) target compounds, (64)Cu-cudotadipep and (64)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Inki, Kim, Min Hwan, Lee, Kyongkyu, Oh, Keumrok, Lim, Hyunwoo, Ahn, Jae Hun, Lee, Yong Jin, Cheon, Gi Jeong, Chi, Dae Yoon, Lim, Sang Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453766/
https://www.ncbi.nlm.nih.gov/pubmed/37627908
http://dx.doi.org/10.3390/diagnostics13162649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453766/
https://www.ncbi.nlm.nih.gov/pubmed/37627908
http://dx.doi.org/10.3390/diagnostics13162649

Ejemplares similares